Literature DB >> 34236448

[Conventional epiphyseal chondrosarcoma of childhood and adolescence: a case report].

R M Mueller1, J Hardes2, A Streitbürger2, M Dudda3, V Vieth4, J Roeder2, S Bertram5, H U Schildhaus5, W Hartmann6, W K Guder2.   

Abstract

INTRODUCTION: Conventional chondrosarcoma is the second most common primary malignant bone tumor and usually occurs at older adult ages. It is rare in childhood and adolescence. CASE HISTORY: This case report presents the treatment course of a 13-year-old boy with a symptomatic chondrogenic tumor of the right distal femur. Histopathologically, an epiphyseal intermediate-grade chondrosarcoma (G2) was diagnosed. DISCUSSION: Based on the following case, potential radiological and histopathological differential diagnoses, such as chondroblastoma or chondroblastic osteosarcoma, are discussed against the background of current standards in orthopedic oncology.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Bone cancer; Children and adolescents; Epiphysis; Megaendoprosthesis; Tumor resection

Mesh:

Year:  2021        PMID: 34236448     DOI: 10.1007/s00113-021-01040-4

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  3 in total

1.  Secondary chondrosarcoma of the pelvis arising from a solitary exostosis in an 11-year-old patient: a case report with 5-year follow-up.

Authors:  Lukas M Nystrom; Barry R DeYoung; Jose A Morcuende
Journal:  Iowa Orthop J       Date:  2013

Review 2.  Chondrosarcoma in childhood: the radiologic and clinical conundrum.

Authors:  Susan M Mosier; Tanvi Patel; Karen Strenge; Andrew D Mosier
Journal:  J Radiol Case Rep       Date:  2012-12-01

Review 3.  What Is the Impact of Diet on Nutritional Diarrhea Associated with Gut Microbiota in Weaning Piglets: A System Review.

Authors:  Jing Gao; Jie Yin; Kang Xu; Tiejun Li; Yulong Yin
Journal:  Biomed Res Int       Date:  2019-12-26       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.